- OmniAb (NASDAQ: OABI) to report Q1 2025 financial results on May 8, 2025.
- Conference call and webcast scheduled at 4:30 PM Eastern Time.
- Participants can join via phone or webcast to discuss financial outcomes and business updates.
OmniAb, Inc. (OABI, Financial), a leader in discovery research technology for the biotechnology industry, will release its financial results for the first quarter of 2025 on Thursday, May 8, 2025. Investors can expect detailed financial disclosures for the period ending March 31, 2025, shortly after the U.S. financial markets close.
A comprehensive conference call and webcast will follow the announcement at 4:30 PM Eastern Time (1:30 PM Pacific Time). Stakeholders interested in participating can dial in through the U.S. number (800) 549-8228, or internationally at (289) 819-1520, using the Conference ID 96760. Additionally, a live and replay webcast, supplemented with slides, will be accessible for broader accessibility.
OmniAb's platform, recognized for its Biological Intelligence™ technology, is instrumental in helping pharmaceutical companies and academic institutions discover next-generation therapeutics. The company's unique methodologies, such as computational antigen design and next-gen sequencing datasets mining, are highly sought after for developing fully-human antibodies and other key therapeutic elements.
Investors and stakeholders are encouraged to join the event to gain insights into OmniAb’s financial performance and updates on ongoing business developments.
